REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 428 filers reported holding REPLIGEN CORP in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $225,464 | +8.0% | 1,418 | -3.9% | 0.01% | 0.0% |
Q2 2023 | $208,795 | -19.5% | 1,476 | -4.2% | 0.01% | -26.7% |
Q1 2023 | $259,444 | -0.6% | 1,541 | -0.1% | 0.02% | -6.2% |
Q4 2022 | $261,076 | -9.3% | 1,542 | +0.1% | 0.02% | -27.3% |
Q3 2022 | $288,000 | +31.5% | 1,540 | +36.6% | 0.02% | +37.5% |
Q1 2021 | $219,000 | – | 1,127 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |